Jacqui Barry, the Chief Clinical Officer for the Cell and Gene Therapy Catapult, was recently interviewed by Labiotech.eu for an article discussing the issues being faced the ATMPs. The article discusses 3 major challenges faced by ATMPs; manufacturing, reimbursement and regulation and what is being done to tackle these. The ATTCs feature as a model being used to increase patient access to these revolutionary medicines